Oestradiol and psychosis: Clinical findings and biological mechanisms

Current Topics in Behavioral Neurosciences

Volumn 8, Issue , 2011, Pages 173-187

  Wieck, Angelika ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bipolar; Mechanism; Oestradiol; Oestrogen; Psychosis; Schizophrenia; SERM; Treatment

Indexed keywords

ESTRADIOL; ESTROGEN; LITHIUM; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; RALOXIFENE; TAMOXIFEN; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HORMONE ACTION; HUMAN; MENSTRUAL CYCLE; MOLECULAR PATHOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; PUERPERAL PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; SEX HORMONE DETERMINATION; UNSPECIFIED SIDE EFFECT; ANIMAL; FEMALE; MALE; MENTAL DISEASE; METABOLISM; REVIEW; SEXUAL DEVELOPMENT;

ANIMALS; ESTRADIOL; FEMALE; HUMANS; MALE; MENTAL DISORDERS; SEX CHARACTERISTICS;

EID: 80053325733     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_127     Document Type: Article

References (80)

1. Aggernaes B, Glenthoj BY, Ebdrup BH, Rasmussen H, Lublin H, Oranje B (2010) Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine. Int J Neuropsychopharmacol 13(10):1383-1395
2. Ahokas A, Aito M, Rimón R (2000) Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 61(3):166-169
3. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Ahmadi-Abhari SA, Sadeghi M, Tabrizi M, Akhondzadeh S (2011) Doubleblind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 129:327-331
4. Backstrom T, Carstensen H, Sodergard R (1976) Concentration of estradiol, testosterone and progesterone in cerebrospinal fluid compared to plasma unbound and total concentrations. J Steroid Biochem 7(6-7):469-472
5. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK (2000) A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 57:95-97
6. Bergemann N, Mundt C, Parzer P, Jannakos I, Nagl I, Salbach B, Klinga K, Runnebaum B, Resch F (2005) Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophr Res 73:357-366
7. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156(2-3):234-258. Review. PubMed PMID: 11549226
8. Brewer CJ, Balen AH (2010) The adverse effects of obesity on conception and implantation. Reproduction 140(3):347-364
9. Brockington I (2005) Menstrual psychosis. World Psychiatry 4(1):9-17
10. Canuso CM, Goldstein JM, Wojcik J et al (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 111:11-20
11. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260
12. Castle DJ, Murray RM (1991) The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 20:285-304
13. Chavez C, Hollaus M, Scarr E, Pavey G, Gogos A, van den Buuse M(2010) The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res 1321:51-59
14. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL (1986) Biologic effects of transdermal estradiol. N Engl J Med 314(25):1615-1620
15. Chua WL, de Izquierdo SA, Kulkarni J, Mortimer A (2005) Estrogen for schizophrenia. Cochrane Database Syst Rev. (4):CD004719
16. Cookson JC (1982) Post-partum mania, dopamine, and estrogens. Lancet 2(8299):672
17. Cousins DA, Butts K, Young AH (2009) The role of dopamine in bipolar disorder. Bipolar Disord 11(8):787-806
18. Creutz LM, Kritzer MF (2002) Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J Comp Neurol 446(3):288-300
19. Darne J, McGarrigle HH, Lachelin GC (1987) Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol:progesterone ratio. Br J Obstet Gynaecol 94(3):227-235
20. Dean C, Williams RJ, Brockington IF (1989) Is puerperal psychosis the same as bipolar manic-depressive disorder? A family study. Psychol Med 19(3):637-647
21. Diamond SB, Rubinstein AA, Dunner DL, Fieve RR (1976) Menstrual problems in women with primary affective illness. Compr Psychiatry 17(4):541-548
22. Gattaz WF, Vogel P, Riecher-Rossler A, Soddu G (1994) Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 36(2):137-139
23. Genazzani AD, Chierchia E, Santagni S, Rattighieri E, Farinetti A, Lanzoni C (2010) Hypothalamic amenorrhea: from diagnosis to therapeutical approach. Ann Endocrinol (Paris) 71 (3):163-169
24. Gogos A, Kwek P, Chavez C, van den Buuse M (2010) Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin-and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors. J Pharmacol Exp Ther 333:218-227
25. Grove-Strawser D, Boulware MI, Mermelstein PG (2010) Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 170(4):1045-1055
26. Hafner H, Riecher A, Maurer K et al (1989) How does gender influence age at first hospitalization for schizophrenia? Psychol Med 19:903-918
27. Hafner H, Behrens S, De Vry J et al (1991) Estradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci 241:65-68
28. Hafner H (2003) Gender differences in schizophrenia. Psychoneuroendocrinology 2(Suppl):17-54
29. Huber TJ, Rollnik J, Wilhelms J, von zur Muhlen A, Emrich HM, Schneider U (2001) Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26(1):27-35
30. Hughes ZA, Liu F, Marquis K, Muniz L, Pangalos MN, Ring RH, Whiteside GT, Brandon NJ (2009) Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders. Curr Mol Pharmacol 2(3):215-236
31. Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS (2006) Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 59(11):1078-1086
32. Jones I, Craddock N (2001) Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 158(6):913-917
33. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, Schwartz MP, Gonzenbach S, Rotrosen JP, Duncan EJ (2004) Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41(3):401-406
34. Karadag F, Akdeniz F, Erten E, Pirildar S, Yucel B, Polat A, AtmacaM(2004) Menstrually related symptom changes in women with treatment-responsive bipolar disorder. Bipolar Disord 6(3): 253-259
35. Kay SR, Opler LA, Lindenmeyer JP (1989) The Positive and Negative Syndrome Scale (Panss): rationale and standardisation. Br J Psychiatry Suppl 7:59-67
36. Kulkarni J, Garland KA, Scaffidi A, Headey B, Anderson R, de Castella A, Fitzgerald P, Davis SR (2006) A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 31:543-547
37. Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, Burger H (2008) Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65(8):955-960
38. Kulkarni J, Gurvich C, Lee SJ, Gilbert H, Gavrilidis E, de Castella A, Berk M, Dodd S, Fitzgerald PB, Davis SR (2010) Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology 35(8):1142-1147
39. Kumar C, McIvor RJ, Davies T, Brown N, Papadopoulos A, Wieck A, Checkley SA, Campbell IC, Marks MN (2003) Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. J Clin Psychiatry 64(2):112-118
40. Kumari V, Konstantinou J, Papadopoulos A, Aasen I, Poon L, Halari R, Cleare AJ (2010) Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women. Neuropsychopharmacology 35:929-937
41. Kumari V (2011) Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia. Curr Top Behav Neurosci. doi:10.1007/7854_2010_117
42. Leibenluft E, Ashman SB, Feldman-Naim S, Yonkers KA (1999) Lack of relationship between menstrual cycle phase and mood in a sample of women with rapid cycling bipolar disorder. Biol Psychiatry 46(4):577-580
43. Lewine RRJ (1988) Gender and schizophrenia. In: Nasrallah NH (ed) Handbook of schizophrenia, vol 3. Elsevier, Amsterdam, pp 121-136
44. Littleton-Kearney MT, Ostrowski NL, Cox DA, Rossberg MI, Hurn PD (2002) Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev 8(3): 309-330
45. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94(4):507-514
46. Marks MN, Wieck A, Checkley SA, Kumar R (1991) Life stress and post-partum psychosis: a preliminary report. Br J Psychiatry Suppl. (10):45-49
47. Marshall KM (2011) Introduction to the interaction between gonadal steroids and the central nervous system. Curr Topics Behav Neurosci. doi:10.1007/7854_2011_136
48. Meulenberg PM, Hofman JA (1989) Salivary progesterone excellently reflects free and total progesterone in plasma during pregnancy. Clin Chem 35(1):168-172
49. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB (2006) New parents and mental disorders: a population-based register study. JAMA 296(21):2582-2589
50. Munk-Olsen T, Laursen TM, Mendelson T, Pedersen CB, Mors O, Mortensen PB (2009) Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 66(2):189-195
51. Neele SJ, Rombouts SA, Bierlaagh MA, Barkhof F, Scheltens P, Netelenbos JC (2001) Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab 86(3):1422-1424
52. Nelson HD, Fu R, Griffin JC, Nygren P, Smith ME, Humphrey L (2009) Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med 151(10):703-715
53. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB (1986) Triphenylethylenes: a new class of protein kinase C inhibitors. J Natl Cancer Inst 76(6):1243-1246
54. Payne JL, Roy PS, Murphy-Eberenz K, Weismann MM, Swartz KL, McInnis MG, Nwulia E, Mondimore FM, MacKinnon DF, Miller EB, Nurnberger JI, Levinson DF, DePaulo JR Jr, Potash JB (2007) Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 99(1-3):221-229
55. Price WA, DiMarzio L (1986) Premenstrual tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry 47(8):415-417
56. Rasgon N, Altshuler L, Fairbanks L et al (2005) Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 7:246-259
57. Reich T, Winokur G (1970) Postpartum psychoses in patients with manic depressive disease. J Nerv Ment Dis 151(1):60-68
58. Riecher-Roessler A, Hafner H, Dutsch-Strobel A et al (1994) Further evidence for a specfic role of estradiol in schizophrenia? Biol Psychiatry 36:492-494
59. Robertson E, Jones I, Haque S, Holder R, Craddock N (2005) Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. Br J Psychiatry 186:258-259
60. Robling SA, Paykel ES, Dunn VJ, Abbott R, Katona C (2000) Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study. Psychol Med 30(6):1263-1271
61. Sánchez MG, Bourque M, Morissette M, Di Paolo T (2010) Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 16(3):e43-e71
62. Schwarz S, Pohl P (1992) Steroid hormones and steroid hormone binding globulins in cerebrospinal fluid studied in individuals with intact and with disturbed blood-cerebrospinal fluid barrier. Neuroendocrinology 55(2):174-182
63. Seeman M (1983) Interaction of sex, age and neuroleptic dose. Compr Psychiatry 24:125-128
64. Seeman MV, Lang M (1990) the role of estrogens in schizophrenia and gender difference. Schizophr Bull 16:185-194
65. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF (1995) Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 38(12):814-818
66. Smejkalova T, Woolley CS (2010) Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J Neurosci 30(48):16137-16148
67. Stone JM, Howes OD, Egerton A, Kambeitz J, Allen P, Lythgoe DJ, O'Gorman RL, McLean MA, Barker GJ, McGuire P (2010) Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry 68(7):599-602
68. Swerdlow NR, Hartman PL, Auerbach PP (1997) Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41(4):452-460
69. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of prepulse inhibition in translationalmodels for schizophrenia research. Psychopharmacology (Berl) 199(3): 331-388
70. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157(2):179-184
71. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW (1988) Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 145(2):179-184
72. Wieck A, Haddad PM (2003) Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 182:199-204
73. Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA (1991) Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. BMJ 303(6803): 613-616
74. Wieck A, Davies RA, Hirst AD, Brown N, Papadopoulos A, Marks MN, Checkley SA, Kumar RC, Campbell IC (2003) Menstrual cycle effects on hypothalamic dopamine receptor function in women with a history of puerperal bipolar disorder. J Psychopharmacol 17(2):204-209
75. Wu CH, Motohashi T, Abdel-Rahman HA, Flickinger GL, Mikhail G (1976) Free and proteinbound plasma estradiol-17 beta during the menstrual cycle. J Clin Endocrinol Metab 43(2): 436-445
76. Wynn JK, Green MF, Sprock J, Light GA, Widmark C, Reist C, Erhart S, Marder SR, Mintz J, Braff DL (2007) Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophr Res 95(1-3): 134-142
77. Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF (2008) Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 65:255-263
78. Zarate CA, Manji HK (2009) Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 23(7):569-582
79. Zarate CA Jr, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, Manji HK (2007) Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9:561-570
80. Zhang M, Ballard ME, Unger LV, Haupt A, Gross G, Decker MW, Drescher KU, Rueter LE (2007) Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine. Behav Brain Res 182(1):1-11